80% of fund managers are now long global semiconductors — flagged today as potentially the most crowded trade in market history. INTC is the week's standout. Short interest collapsed 55% in a single week to just 103,000 shares. The stock has rallied 15%. Cost to borrow edged up to 7.7% as shorts scrambled to cover. Options markets are buzzing, with active positioning across the June 22 and June 26 expiries. MU reports Q3 earnings on Wednesday June 24. Its option chain spans 23 expiry dates — a signal of heavy speculative interest heading into the print.
The Walton Family Holdings Trust filed a $533 million disposal of WMT shares on June 16. It is one of the largest single-day family trust sales on record. At AMAT, seven insiders filed sales this week. CEO Gary Dickerson sold roughly $39 million across June 15–16 at around $590–$597 per share. AMAT has rallied sharply this year. Executives appear to be locking in gains. Options traders are hedging with near-term puts.
MRNA cleared a major hurdle today. The FDA advisory committee backed its flu vaccine 9-0. The vote is a significant catalyst for a stock that has struggled. Options activity flagged this name as a wildcard heading into the panel.
ACN saw its consensus price target cut to $200.89 from $208.16. LULU also drew fresh cuts, with the target falling to $132.16. On the positive side, LLY received a small target lift to $1,218.72. Analyst support for Lilly remains near-universal, with 22 Buy ratings and just one Sell.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
